Personalized Financial Incentives for Obesity
(Log2LoseAI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if personalized financial rewards can help individuals adhere to a weight-loss program by tracking their diet and losing weight. Participants may receive monetary rewards for progress in weight loss and diet tracking. The trial seeks individuals who are at least 18 years old, have obesity (a BMI of 30 or higher), wish to lose weight, and are willing to join virtual group classes and use a smartphone app to track their progress. As an unphased trial, participants can contribute to innovative research that may lead to new weight-loss strategies.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but certain medications like insulin, sulfonylureas, meglitinides, and high doses of some diuretics are not allowed. It's best to discuss your specific medications with the trial team.
What prior data suggests that personalized financial incentives are safe for weight loss programs?
Research has shown that using personalized financial rewards to aid weight loss is generally safe. One study found that these rewards not only facilitated weight loss but also did not cause major side effects, indicating the approach is usually well-accepted. A review of studies from 1972 to 2010 confirmed that financial incentives can help people manage their weight without causing harm. While these findings are promising, individuals should consider their own health before starting any new program.12345
Why are researchers excited about this trial?
Researchers are excited about personalized financial incentives for obesity because they offer a novel approach that differs from standard treatments like diet, exercise, or medications. Unlike traditional methods, this approach uses financial rewards to motivate individuals based on their unique responses to incentives. It's a personalized strategy that could make weight loss efforts more effective by tapping into what motivates each person. This method could potentially transform how we approach obesity management, making it more tailored and engaging for individuals.
What evidence suggests that personalized financial incentives are effective for weight loss?
Research has shown that offering money can help people lose weight. For example, when financial rewards were added to weight loss programs, teenagers with severe obesity lost more weight and body fat. Another study found that setting goals and offering money for reaching them helped people lose weight more effectively than just providing resources. These financial rewards proved cost-effective, especially for those with low incomes. In this trial, participants may receive personalized financial incentives for weight loss if their performance indicates a positive response to such incentives, encouraging them to stick to their weight loss goals by rewarding their progress.12678
Are You a Good Fit for This Trial?
This trial is for adults with obesity (BMI ≥30 kg/m2) who want to lose weight and are willing to attend virtual classes, use a Fitbit app daily, and have reliable internet access. They must be able to stand on a scale, speak English, and join video calls. Excluded are those over 380lbs or with recent significant weight loss, current cancer treatment (except certain skin cancers), unstable heart disease or advanced kidney disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a clinician-facilitated, group-based behavioral weight-loss program with personalized financial incentives for 24 weeks
Follow-up
Participants are monitored for retention and changes in body weight after the treatment phase
What Are the Treatments Tested in This Trial?
Interventions
- Personalized Financial Incentives
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator